Advent Pharma Ltd.

DSE:ADVENT Stock Report

Market Cap: ৳1.5b

Advent Pharma Past Earnings Performance

Past criteria checks 1/6

Advent Pharma's earnings have been declining at an average annual rate of -11.6%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 0.3% per year. Advent Pharma's return on equity is 4.5%, and it has net margins of 12.8%.

Key information

-11.6%

Earnings growth rate

-11.6%

EPS growth rate

Pharmaceuticals Industry Growth11.0%
Revenue growth rate0.3%
Return on equity4.5%
Net Margin12.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Advent Pharma makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

DSE:ADVENT Revenue, expenses and earnings (BDT Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2452267830
30 Jun 2457284860
31 Mar 2456992910
31 Dec 2356492920
30 Sep 2355893900
30 Jun 2355899880
31 Mar 2355298870
31 Dec 2254899880
30 Sep 2254299870
30 Jun 2253098870
31 Mar 22526110920
31 Dec 21507104880
30 Sep 21504116830
30 Jun 21504114790
31 Mar 2144594610
31 Dec 2046494620
30 Sep 2049298670
30 Jun 20534117710
31 Mar 20589140760
31 Dec 19604165700
30 Sep 19619169710
30 Jun 19602158710
31 Mar 19606172800
31 Dec 18541144810
30 Sep 18456112770
30 Jun 1839687760
31 Mar 1835764600
30 Sep 1731857540
30 Jun 1728549500
30 Jun 1622828470

Quality Earnings: ADVENT has high quality earnings.

Growing Profit Margin: ADVENT's current net profit margins (12.8%) are lower than last year (16.7%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: ADVENT's earnings have declined by 11.6% per year over the past 5 years.

Accelerating Growth: ADVENT's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: ADVENT had negative earnings growth (-28.5%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (1.7%).

Return on Equity

High ROE: ADVENT's Return on Equity (4.5%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 02:33
End of Day Share Price 2025/01/09 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Advent Pharma Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution